BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

330 related articles for article (PubMed ID: 32203141)

  • 21. Stereotyped B-cell receptor is an independent risk factor of chronic lymphocytic leukemia transformation to Richter syndrome.
    Rossi D; Spina V; Cerri M; Rasi S; Deambrogi C; De Paoli L; Laurenti L; Maffei R; Forconi F; Bertoni F; Zucca E; Agostinelli C; Cabras A; Lucioni M; Martini M; Magni M; Deaglio S; Ladetto M; Nomdedeu JF; Besson C; Ramponi A; Canzonieri V; Paulli M; Marasca R; Larocca LM; Carbone A; Pileri SA; Gattei V; Gaidano G
    Clin Cancer Res; 2009 Jul; 15(13):4415-22. PubMed ID: 19509140
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Factors predicting survival in chronic lymphocytic leukemia patients developing Richter syndrome transformation into Hodgkin lymphoma.
    Mauro FR; Galieni P; Tedeschi A; Laurenti L; Del Poeta G; Reda G; Motta M; Gozzetti A; Murru R; Caputo MD; Campanelli M; Frustaci AM; Innocenti I; Raponi S; Guarini A; Morabito F; Foà R; Gentile M
    Am J Hematol; 2017 Jun; 92(6):529-535. PubMed ID: 28295527
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Clinical utility of chromosomal microarray in establishing clonality and high risk features in patients with Richter transformation.
    Hess B; Kalmuk J; Znoyko I; Schandl CA; Wagner-Johnston N; Mazzoni S; Hendrickson L; Chiad Z; Greenwell IB; Wolff DJ
    Cancer Genet; 2022 Jan; 260-261():18-22. PubMed ID: 34808593
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Active Akt signaling triggers CLL toward Richter transformation via overactivation of Notch1.
    Kohlhaas V; Blakemore SJ; Al-Maarri M; Nickel N; Pal M; Roth A; Hövelmeyer N; Schäfer SC; Knittel G; Lohneis P; Nikolic M; Wiederstein JL; Franitza M; Georgomonolis T; Reinart N; Herling M; Herling C; Hartmann EM; Rosenwald A; Klapper W; Büttner R; Moia R; Rossi D; Boldorini R; Gaidano G; Frenzel LP; Reinhardt HC; Brüning JC; Hallek M; Krüger M; Peifer M; Pallasch CP; Wunderlich FT
    Blood; 2021 Feb; 137(5):646-660. PubMed ID: 33538798
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Richter syndrome: molecular insights and clinical perspectives.
    Rossi D; Gaidano G
    Hematol Oncol; 2009 Mar; 27(1):1-10. PubMed ID: 19206112
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Computed tomography textural analysis for the differentiation of chronic lymphocytic leukemia and diffuse large B cell lymphoma of Richter syndrome.
    Reinert CP; Federmann B; Hofmann J; Bösmüller H; Wirths S; Fritz J; Horger M
    Eur Radiol; 2019 Dec; 29(12):6911-6921. PubMed ID: 31236702
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Richter syndrome in chronic lymphocytic leukemia: updates on biology, clinical features and therapy.
    Jamroziak K; Tadmor T; Robak T; Polliack A
    Leuk Lymphoma; 2015 Jul; 56(7):1949-58. PubMed ID: 25356923
    [TBL] [Abstract][Full Text] [Related]  

  • 28. How we treat Richter syndrome.
    Parikh SA; Kay NE; Shanafelt TD
    Blood; 2014 Mar; 123(11):1647-57. PubMed ID: 24421328
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Rare Richter Transformation of Chronic Lymphocytic Lymphoma to Hodgkin Lymphoma.
    Buckley T; Inamdar A; Mikhail NH; Loo A; Cohen S
    Am J Case Rep; 2021 Dec; 22():e932904. PubMed ID: 34934038
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Pembrolizumab in patients with CLL and Richter transformation or with relapsed CLL.
    Ding W; LaPlant BR; Call TG; Parikh SA; Leis JF; He R; Shanafelt TD; Sinha S; Le-Rademacher J; Feldman AL; Habermann TM; Witzig TE; Wiseman GA; Lin Y; Asmus E; Nowakowski GS; Conte MJ; Bowen DA; Aitken CN; Van Dyke DL; Greipp PT; Liu X; Wu X; Zhang H; Secreto CR; Tian S; Braggio E; Wellik LE; Micallef I; Viswanatha DS; Yan H; Chanan-Khan AA; Kay NE; Dong H; Ansell SM
    Blood; 2017 Jun; 129(26):3419-3427. PubMed ID: 28424162
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Artificial intelligence strategy integrating morphologic and architectural biomarkers provides robust diagnostic accuracy for disease progression in chronic lymphocytic leukemia.
    El Hussein S; Chen P; Medeiros LJ; Wistuba II; Jaffray D; Wu J; Khoury JD
    J Pathol; 2022 Jan; 256(1):4-14. PubMed ID: 34505705
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Diagnosis of Richter transformation in chronic lymphocytic leukemia: histology tips the scales.
    Federmann B; Mueller MR; Steinhilber J; Horger MS; Fend F
    Ann Hematol; 2018 Oct; 97(10):1859-1868. PubMed ID: 29947976
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Chronic lymphocytic leukemia patient-derived xenografts recapitulate clonal evolution to Richter transformation.
    Playa-Albinyana H; Arenas F; Royo R; Giró A; López-Oreja I; Aymerich M; López-Guerra M; Frigola G; Beà S; Delgado J; Garcia-Roves PM; Campo E; Nadeu F; Colomer D
    Leukemia; 2024 Mar; 38(3):557-569. PubMed ID: 38017105
    [TBL] [Abstract][Full Text] [Related]  

  • 34. An unusual presentation of a chronic lymphocytic leukemia patient with 17p deletion after reduced-intensity transplantation: Richter syndrome and concomitant graft-versus-host disease--case report.
    Salihoglu A; Ozbalak M; Keskin D; Tecimer T; Soysal T; Ferhanoglu B
    Transplant Proc; 2013 Sep; 45(7):2845-8. PubMed ID: 23747187
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Hodgkin transformation of chronic lymphocytic leukemia: Incidence, outcomes, and comparison to de novo Hodgkin lymphoma.
    Parikh SA; Habermann TM; Chaffee KG; Call TG; Ding W; Leis JF; Macon WR; Schwager SM; Ristow KM; Porrata LF; Kay NE; Slager SL; Shanafelt TD
    Am J Hematol; 2015 Apr; 90(4):334-8. PubMed ID: 25581025
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Etiology of Ibrutinib Therapy Discontinuation and Outcomes in Patients With Chronic Lymphocytic Leukemia.
    Maddocks KJ; Ruppert AS; Lozanski G; Heerema NA; Zhao W; Abruzzo L; Lozanski A; Davis M; Gordon A; Smith LL; Mantel R; Jones JA; Flynn JM; Jaglowski SM; Andritsos LA; Awan F; Blum KA; Grever MR; Johnson AJ; Byrd JC; Woyach JA
    JAMA Oncol; 2015 Apr; 1(1):80-7. PubMed ID: 26182309
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Combined Haploidentical and Umbilical Cord Blood Allogeneic Stem Cell Transplantation for High-Risk Lymphoma and Chronic Lymphoblastic Leukemia.
    Hsu J; Artz A; Mayer SA; Guarner D; Bishop MR; Reich-Slotky R; Smith SM; Greenberg J; Kline J; Ferrante R; Phillips AA; Gergis U; Liu H; Stock W; Cushing M; Shore TB; van Besien K
    Biol Blood Marrow Transplant; 2018 Feb; 24(2):359-365. PubMed ID: 29128555
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Molecular history of Richter syndrome: origin from a cell already present at the time of chronic lymphocytic leukemia diagnosis.
    Rossi D; Spina V; Forconi F; Capello D; Fangazio M; Rasi S; Martini M; Gattei V; Ramponi A; Larocca LM; Bertoni F; Gaidano G
    Int J Cancer; 2012 Jun; 130(12):3006-10. PubMed ID: 21796624
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Outcomes of Patients With Chronic Lymphocytic Leukemia and Richter's Transformation After Transplantation Failure.
    Rozovski U; Benjamini O; Jain P; Thompson PA; Wierda WG; O'Brien S; Burger JA; Ferrajoli A; Faderl S; Shpall E; Hosing C; Khouri IF; Champlin R; Keating MJ; Estrov Z
    J Clin Oncol; 2015 May; 33(14):1557-63. PubMed ID: 25847930
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Early autologous stem cell transplantation for chronic lymphocytic leukemia: long-term follow-up of the German CLL Study Group CLL3 trial.
    Dreger P; Döhner H; McClanahan F; Busch R; Ritgen M; Greinix H; Fink AM; Knauf W; Stadler M; Pfreundschuh M; Dührsen U; Brittinger G; Hensel M; Schetelig J; Winkler D; Bühler A; Kneba M; Schmitz N; Hallek M; Stilgenbauer S;
    Blood; 2012 May; 119(21):4851-9. PubMed ID: 22490331
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 17.